Detail akcie AptarGroup Inc online

Business Summary: AptarGroup, Inc. is engaged in the design and manufacturing of drug and consumer product dosing, dispensing, and protection technologies. The Company serves diversified end markets including pharmaceutical, fragrance, facial skincare, color cosmetics, food, beverage, personal care, and home care. It also manufactures and sells elastomeric primary packaging components. It operates through three segments, which include Pharma segment, Beauty segment, and Closures segment. The Pharma segment is a supplier of nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and health care markets worldwide. The Beauty segment sells pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care, and home care markets. The Closures segment includes dispensing and non-dispensing solutions that enable product delivery without removal of the cap and are used across multiple consumer end markets.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Aptargroup Inc revenues increased 5% to $3.78B. Net income increased 5% to $392.8M. Revenues reflect Aptar Pharma segment increase of 6% to $1.74B, Aptar Beauty segment increase of 7% to $1.31B, Other Europe segment increase of 5% to $788.1M, China segment increase of 25% to $194.4M. Net income also reflects Equity in results of affiliates increase from $87K to $7.4M (income).